DHANIMAV Trademark

Trademark Overview


On Tuesday, September 7, 2021, a trademark application was filed for DHANIMAV with the United States Patent and Trademark Office. The USPTO has given the DHANIMAV trademark a serial number of 97014638. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, August 2, 2024. This trademark is owned by Kiniksa Pharmaceuticals, Ltd.. The DHANIMAV trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, anti-inflammatories; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare diseases and disorders
dhanimav

General Information


Serial Number97014638
Word MarkDHANIMAV
Filing DateTuesday, September 7, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, August 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2023

Trademark Statements


Goods and Servicespharmaceutical preparations, namely, anti-inflammatories; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare diseases and disorders
Translation of Words in MarkThe wording DHANIMAV has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKiniksa Pharmaceuticals, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Party NameKiniksa Pharmaceuticals, Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHamilton HM11
BM

Trademark Events


Event DateEvent Description
Friday, September 10, 2021NEW APPLICATION ENTERED
Sunday, October 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 10, 2022ASSIGNED TO EXAMINER
Friday, June 17, 2022NON-FINAL ACTION WRITTEN
Friday, June 17, 2022NON-FINAL ACTION E-MAILED
Friday, June 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 1 FILED
Monday, September 18, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 20, 2024SOU EXTENSION 2 GRANTED
Thursday, March 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2024SOU EXTENSION 2 FILED
Wednesday, March 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 2, 2024SOU EXTENSION 3 FILED
Friday, August 2, 2024SOU EXTENSION 3 GRANTED